211
Views
9
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis

, &
Pages 631-638 | Published online: 06 Apr 2017

References

  • The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf200752759217508116
  • Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf20075216317817508120
  • StevenPCursiefenCAnti-inflammatory treatment in dry eye diseaseKlin Monbl Augenheilkd20122295500505 German22592340
  • van de WouwDSvan der MeulenIJvan VlietJMLapid-GortzakRNieuwendaalCPvan den BergTJIncreased straylight in patients with keratoconjunctivitis SiccaCornea201635674975327032024
  • The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf2007529310717508117
  • KlingenbergHOExcipient update – a real eyeopener: advances in hyaluronic acid for ophthalmologyDrug Dev Deliver2013134
  • ShimmuraSOnoMShinozakiKSodium hyaluronate eyedrops in the treatment of dry eyesBr J Ophthalmol19957911100710118534643
  • TroianoPMonacoGEffect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over studyCornea200827101126113019034126
  • LiuXMHarmonPSMaziarzEPRahMJMercheaMMComparative studies of hyaluronan in marketed ophthalmic productsOptom Vis Sci2014911323824366432
  • BaudouinCCochenerBPisellaPJRandomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye diseaseEur J Ophthalmol201222575176122287172
  • BaeyensVBronABaudouinCVismed/Hylovis Study GEfficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye diseaseJ Fr Ophtalmol201235641241922483761
  • LeeJHAhnHSKimEKKimTIEfficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye diseaseCornea201130217517921045674
  • Lopez-de la RosaAPinto-FragaJBlazquez ArauzoFUrbano RodriguezRGonzalez-GarciaMJSafety and efficacy of an artificial tear containing 0.3% hyaluronic acid in the management of moderate-to-severe dry eye diseaseEye Contact Lens Epub2016526
  • Pinto-FragaJLopez-de la RosaABlazquez ArauzoFUrbano RodriguezRGonzalez-GarciaMJEfficacy and safety of 0.2% hyaluronic acid in the management of dry eye diseaseEye Contact Lens2017431576326783978
  • TepingCHyaluronsäureThieme Drug Report201023112
  • De Saint JeanMDebbaschCBrignoleFWarnetJMBaudouinCRelationship between in vitro toxicity of benzalkonium chloride (BAC) and preservative-induced dry eyeAdv Exp Med Biol2002506Pt A69770212613979
  • BronAJEvansVESmithJAGrading of corneal and conjunctival staining in the context of other dry eye testsCornea200322764065014508260
  • RomanchukKGFluorescein. Physiochemical factors affecting its fluorescenceSurv Ophthalmol19822652692837046118
  • KimJFoulksGNEvaluation of the effect of lissamine green and rose bengal on human corneal epithelial cellsCornea199918332833210336037
  • McLeodSALikert Scale homepage on the Internet2008 Available from: www.simplypsychology.org/likert-scale.htmlAccessed September 29, 2016
  • DoughtyMJFluorescein-tear breakup time as an assessment of efficacy of tear replacement therapy in dry eye patients: a systematic review and meta-analysisOcul Surf201412210011124725322
  • BrjeskyVVMaychukYFPetrayevskyAVNagorskyPGUse of preservative-free hyaluronic acid (Hylabak®) for a range of patients with dry eye syndrome: experience in RussiaClin Ophthalmol201481169117724970995
  • FoulksGNChallenges and pitfalls in clinical trials of treatments for dry eyeOcul Surf200311203017075626
  • DreyfussJLRegatieriCVCoelhoBAltered hyaluronic acid content in tear fluid of patients with adenoviral conjunctivitisAn Acad Bras Cienc201587145546225714075
  • HoWTChiangTHChangSWChenYHHuFRWangIJEnhanced corneal wound healing with hyaluronic acid and high-potassium artificial tearsClin Exp Optom201396653654123782164
  • MacriAScanarottiCBassiAMEvaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15% and vitamin B12 eye dropsGraefes Arch Clin Exp Ophthalmol2015253342543025398660
  • AbelsonMBLafonA3,500 years of artificial tearsRev Ophthalmol201414124447
  • NebbiosoMFameliVGharbiyaMSacchettiMZicariAMLambiaseAInvestigational drugs in dry eye diseaseExpert Opin Investig Drugs2016251214371446